Stock comparison
Genpact Limited
Lam Research
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
G
Genpact Limited
Market cap
$5.41B
Sector
Technology
LRCX
Lam Research
Market cap
$381.86B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | G | LRCX | Winner |
|---|---|---|---|
| Warren Buffett | 58C | 78B | LRCX |
| Benjamin Graham | 52C | 88A | LRCX |
| Philip Fisher |
Side-by-side metrics
| Metric | G | LRCX |
|---|---|---|
| Market cap | $5.41B | $381.86B |
| P/E (TTM) | 9.3x | 55.4x |
| EV/EBIT | 8.5x | 62.9x |
| ROIC (TTM) | 12.78% | 42.79% |
| Gross margin | 36.43% | 49.98% |
| Net margin | 11.04% | 30.94% |
| Revenue CAGR 5y | 6.01% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
G leads on
- EV/EBIT8.5xvs 62.9x+86%
- Dividend yield2.23%vs 0.34%+85%
- P/E (TTM)9.3xvs 55.4x+83%
- EPS CAGR 5y12.72%vs 11.27%
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.